臺北榮民總醫院

:::

齊振達 (Chen-Ta Chi)

掛號

[簡介]

學歷
經歷
現職：
- - 迄今臺北榮民總醫院內科部胃腸肝膽科主治醫師
- - 迄今國立陽明交通大學醫學系講師
- - 迄今國立陽明交通大學臨床醫學研究所博士(在學中)
經歷：
- - 台北榮民總醫院內科部總醫師
- - 台北榮民總醫院內科部胃腸肝膽科總醫師
- - 台北榮民總醫院內科部住院醫師
醫療專長
1. 肝炎、肝硬化及其合併症治療消化道疾病及膽道疾病腹部超音波及消化道內視鏡診斷及治療
證照

內科專科醫師消化系內科專科醫師消化系內視鏡專科醫師
語言專長

國語台語英語

[著作]

1. Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection. Wu KC, Lee IC, Chi CT, Lei HJ, Chau GY, Yeh YC, Su CW, Huo TI, Chao Y, Lin HC, Hou MC, Huang YH. Am J Cancer Res. 2021 Nov 15;11(11):5526-5542. eCollection 2021.

2. Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection. Chi CT, Lee IC, Lee RC, Hung YW, Su CW, Hou MC, Chao Y, Huang YH. Cancers (Basel). 2021 Aug 27;13(17):4325. doi: 10.3390/cancers13174325.

3. Redefining Tumor Burden in Patients with Intermediate-Stage Hepatocellular Carcinoma: The Seven-Eleven Criteria. Hung YW, Lee IC, Chi CT, Lee RC, Liu CA, Chiu NC, Hwang HE, Chao Y, Hou MC, Huang YH. Liver Cancer, 2021. doi: 10.1159/000517393. Epub 2021 July 22.

4. Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan. Chi CT, Chen CY, Su CW, Chen PY, Chu CJ, Lan KH, Lee IC, Hou MC, Huang YH. J Microbiol Immunol Infect. 2021 Jun;54(3):385-395. doi: 10.1016/j.jmii.2019.09.006. Epub 2019 Nov 14.

5. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection. Chi CT, Chau GY, Lee RC, Chen YY, Lei HJ, Hou MC, Chao Y, Huang YH. J Formos Med Assoc. 2020 Jan;119(1 Pt 1):125-133. doi: 10.1016/j.jfma.2019.02.012. Epub 2019 Mar 12.